KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-Current Deferred Tax Liability: 2009-2024

Historic Non-Current Deferred Tax Liability for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $483.0 million.

  • Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability fell 25.84% to $399.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.0 million, marking a year-over-year decrease of 25.84%. This contributed to the annual value of $483.0 million for FY2024, which is 20.30% down from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability is $483.0 million, which was down 20.30% from $606.0 million recorded in FY2023.
  • Teva Pharmaceutical Industries' 5-year Non-Current Deferred Tax Liability high stood at $964.0 million for FY2020, and its period low was $483.0 million during FY2024.
  • In the last 3 years, Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability had a median value of $548.0 million in 2022 and averaged $545.7 million.
  • In the last 5 years, Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability crashed by 30.10% in 2022 and then grew by 10.58% in 2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability (Yearly) stood at $964.0 million in 2020, then dropped by 18.67% to $784.0 million in 2021, then plummeted by 30.10% to $548.0 million in 2022, then grew by 10.58% to $606.0 million in 2023, then fell by 20.30% to $483.0 million in 2024.